04 GI/2018 (1)

jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99

vlk/kj.k EXTRAORDINARY

Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii)

izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY

la- 02] ubZ fnYyh] lkseokj] tuojh 1] 2018@ikS"k 11] 1939 No. 02] NEW DELHI, MONDAY, JANUARY 1, 2018/PAUSHA 11, 1939

jlk;u vkSj moZjd ea=ky;jlk;u vkSj moZjd ea=ky;jlk;u vkSj moZjd ea=ky;jlk;u vkSj moZjd ea=ky;

¼vkS”k/k foHkkx½¼vkS”k/k foHkkx½¼vkS”k/k foHkkx½¼vkS”k/k foHkkx½

¼jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k½¼jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k½¼jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k½¼jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k½

vkns’kvkns’kvkns’kvkns’k

ubZ fnYyh] 1 tuojh] 2018

dkdkdkdk----vkvkvkvk---- 02020202¼v½¼v½¼v½¼v½.—Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½] rkjh[k 30 ebZ] 2013 vkSj dk-vk- 701¼v½] rkjh[k 10 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkns'k] 2013 ds iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼6½ eas fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½] ¼4½] vkSj ¼5½ eas rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk] bdkbZ ¼;wfuV½ vkSj fofuekZrk vkSj foi.ku dEifu;ksa ds uke lfgr LraHk ¼2½ esa dh rRLFkkuh izfof"V esa ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds :i esa fu;r djrh gSA

lkj.khlkj.khlkj.khlkj.kh

ØØØØzzzz----lalalala---- vuqlwfpr fofufeZfr dk vuqlwfpr fofufeZfr dk vuqlwfpr fofufeZfr dk vuqlwfpr fofufeZfr dk uke@czkaM dk ukeuke@czkaM dk ukeuke@czkaM dk ukeuke@czkaM dk uke

izcyrkizcyrkizcyrkizcyrk bdkbZbdkbZbdkbZbdkbZ fofuekZrk vkSj foi.ku daiuh fofuekZrk vkSj foi.ku daiuh fofuekZrk vkSj foi.ku daiuh fofuekZrk vkSj foi.ku daiuh [kqnjk ewY; [kqnjk ewY; [kqnjk ewY; [kqnjk ewY; ¼#¼#¼#¼#----½½½½

¼1½¼1½¼1½¼1½ ¼2½¼2½¼2½¼2½ ¼3½¼3½¼3½¼3½ ¼4½¼4½¼4½¼4½ ¼5½¼5½¼5½¼5½ ¼6½¼6½¼6½¼6½

1. fdYuhMkbfiu $ feVksizksyksy xksyh

izR;sd fQYe fyfir ck;ys;MZ xksyh esa:

fdYuhMkbfiu 10 fexzk-] feVksizksyksy lqlhusV vkbZih 47-5 fexzk- ds cjkcj feVksizksyksy VkjVªsV 50 fexzk- ¼bZvkj½

1 xksyh eSllZ I;ksj ,aM D;ksj gsYFkds;j izkbosV fyfeVsM@ eSllZ buVkl QkekZL;wfVdYl izk- fy-

7.346

2. esVQksfeZu $ fXyesfijkbM $ oksXyhckWl xksyh

izR;sd xksyh esa%

esVQksfeZu ,plh,y 500 fexzk- ¼lLVsaM jhfyt QkseZ esa½] fXyesfijkbM 1 fexzk-] oksXyhckWl 0-3 fexzk-

1 xksyh eSllZ luXyks QkekZL;wfVdYl izk- fy-@eSllZ buVkl QkekZL;wfVdYl fy-

8.17

2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

3. jkslwoklVkfVu $ DyksfiMksxzsy

dSIlwy izR;sd gkMZ tsysfVu dSIlwy esa% jkstqoklVkfVu dSfY’k;e vkbZih ds cjkcj jkstqoklVkfVu 20 fexzk-] DyksfiMksxzsy ckblYQsV ds cjkcj DyksfiMksxzsy 75 fexzk-

1 dSIlwy eSllZ lkbuksdse QkekZL;wfVdYl fy-@eSllZ dSfMyk QkekZL;wfVdYl fy-

7.80

4. VsyfelkjVu $ DyksjFkkfyMkWu xksyh ¼fVxkVsy lh,p 80½

izR;sd fQYe vfyfir xksyh esa% VsyfelkjVu vkbZih 80 fexzk-] DyksjFkkfyMkWu vkbZih 12-5 fexzk-

1 xksyh eSllZ lu QkekZ yscksjsVksfjt fy-

6.713

5. jkstqoklVkfVu $ DyksfiMksxzsy dSIlwy

izR;sd gkMZ tsysfVu dSIlwy esa% jkstqoklVkfVu dSfY’k;e vkbZih ds cjkcj jkstqoklVkfVu 20 fexzk- ¼IysVl esa½] DyksfiMksxzsy fclYQsV vkbZih ds cjkcj DyksfiMksxzsy 75 fexzk- ¼fiySVl esa½

1 dSIlwy eSllZ lkbuksdse QkekZL;wfVdYl fy-@eSllZ tk;Ml fy-

7.80

6. iSjkflVkeksy $ dSfQu $MkbZQsfuMªkekbu ,plh,y esyh,V $ QsuhysÝhu gkbMªksDyksjkbM xksyh

¼lkbul 77½

izR;sd vfyfir xksyh esa% iSjkflVkeksy vkbZih 500 fexzk-] dSfQu ¼,ugkbMªl½- 30 fexzk] MkbZQsfuMªkekbu ,plh,y 25 fexzk-] QsuhysÝhu gkbMªksDyksjkbM vkbZih 5 fexzk-

1 xksyh eSllZ MsYl yscksjsVksfjt fy- 2.57

7. ,VksjoklVkfVu $ DyksfiMksxzsy dSIlwy

izR;sd gkMZ tsysfVu dSIlwy esa% ,VksjoklVkfVu dSfY’k;e vkbZih ds cjkcj ,VksjoklVkfVu 10 fexzk-] DyksfiMksxzsy ckblYQsV vkbZih ds cjkcj DyksfiMksxzsy 75 fexzk-

1 dSIlwy

eSllZ lk;uksdse QkekZL;wfVdYl fy-@eSllZ bfjl ykbZQ lkbalsl fy-

8.394

8. ,VksjoklVkfVu $ DyksfiMksxzsy dSIlwy

izR;sd gkMZ tsysfVu dSIlwy esa% ,VksjoklVkfVu dSfY’k;e vkbZih ds cjkcj ,VksjoklVkfVu 20 fexzk-] DyksfiMksxzsy ckblYQsV vkbZih ds cjkcj DyksfiMksxzsy 75 fexzk-

1 dSIlwy

eSllZ lk;uksdse QkekZL;wfVdYl fy-@eSllZ ,fjl ykbZQ lkbalsl fy-

10.596

9. fXyDyktkbM $ esVQksfeZu xksyh ¼Xykbpsd ,e $½

izR;sd vfyfir xksyh esa: fXyDyktkbM vkbZih 40 fexzk-] esVQksfeZu gkbMªksDyksjkbM 500 fexzk-

1 xksyh eSllZ ,dEl MªXl ,aM QkekZL;wfVdYl fy-@eSllZ buMksdks jsfeMht fy-

4.354

10. ,VksjoklVkfVu $ DyksfiMksxzsy dSIlwy ¼,Vksdksj

lhoh 20 fexzk-½

izR;sd gkMZ tsysfVu dSIlwy esa% ,VksjoklVkfVu dSfY’k;e vkbZih ds cjkcj ,VksjoklVkfVu 20 fexzk- ¼izR;sd nks fQYe fyfir xksyh esa ,VksjoklVkfVu 10 fexzk-½] DyksfiMksxzsy ckblYQsV vkbZih ds cjkcj DyksfiMksxzsy 75 fexzk- ¼izR;sd nks fQYe fyfir xksyh esa 37-5 fexzk-½]

1 dSIlwy

eSllZ foaMykl ck;ksVsd izk- fy-@eSllZ MkW- jsM~Mht yscksjsVksfjt fy-

10.596

11. ,VksjoklVkfVu $ DyksfiMksxzsy dSIlwy ¼,okl

20 xksYM½

izR;sd dSIlwy esa% ,VksjoklVkfVu dSfY’k;e vkbZih ds cjkcj ,VksjoklVkfVu 20 fexzk- ¼izR;sd fQYe fyfir xksyh esa½] DyksfiMksxzsy ckblYQsV vkbZih ds cjkcj DyksfiMksxzsy 75 fexzk- ¼izR;sd nks fQYe fyfir xksyh esa 37-5 fexzk-½]

1 dSIlwy

eSllZ ekbØks ysc- fy- 10.596

12. ,VksjoklVkfVu $ DyksfiMksxzsy dSIlwy ¼,lfVu 20 xksYM½

izR;sd dSIlwy esa% ,VksjoklVkfVu dSfY’k;e vkbZih ds cjkcj ,VksjoklVkfVu 20 fexzk- ¼izR;sd fQYe fyfir xksyh esa½] DyksfiMksxzsy ckblYQsV vkbZih ds cjkcj DyksfiMksxzsy 75 fexzk- ¼izR;sd nks fQYe fyfir xksyh esa 37-5 fexzk-½]

1 dSIlwy

eSllZ ekbØks ysc- fy- 10.596

¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3

uksV %uksV %uksV %uksV %

¼d½ mi;qZDr nh xbZ fofufnZ"V QkWewZys'ku ds fofuekZrk vFkkZr tks ÞubZ Mªxß Mhihlhvks] 2013 ds iSjkxzkQ 2¼;w½ ds rgr mi;qZDr nh xbZ lkj.kh ds LraHk ¼6½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA

¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼6½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSaA

¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼6½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V esa vf/klwpuk dh rkjh[k ls ,d ewY; lwph ,uihih, dks vkbZihMh,e,l ds ek/;e ls tkjh djsaA

¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds 24 ¼4½ ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn’̀; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA

¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr vuqc) ewY; fu/kkZj.k@la'kks/ku ds fy, QkWeZ I ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkZfjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds vUrxZr tSlk fd dsUnzh;@jkT; ykblsflax vkWFkksfjVh ds l{ke izkf/kdkjh }kjk esU;wQsDpfjax ykblsal eatwjh ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA

¼p½ mi;qZDr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa lEcfU/kr fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds vuqlwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls de ls de N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA

¼N½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufeZfr;ksa vkSj fofufnZ"V 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA

¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA

[dka- la-@184@52@2017@,Q@Qk- la- 8¼52½@2017@Mhih@,uihih,&fMoh- II]

cythr flag] ] ] ] lgk;d funs'kd

13. jkstqoklVkfVu$ DyksfiMksxzsy dSIlwy

izR;sd gkMZ tsysfVu dSIlwy esa%

jkstqoklVkfVu dSfY’k;e vkbZih ds cjkcj jkstqoklVkfVu 10 fexzk-]

DyksfiMksxzsy ckblYQsV ds cjkcj DyksfiMksxzsy 75 fexzk-

1 dSIlwy eSllZ lkbuksdse QkekZL;wfVdYl fy-@eSllZ bfjl ykbZQ lkbaflt fy-

13.37

14. jkstqoklVkfVu$DyksfiMksxzsy dSIlwy

izR;sd gkMZ tsysfVu dSIlwy esa%

jkstqoklVkfVu dSfY’k;e vkbZih ds cjkcj jkstqoklVkfVu 20 fexzk-]

DyksfiMksxzsy ckblYQsV ds cjkcj DyksfiMksxzsy 75 fexzk-

1 dSIlwy eSllZ lkbuksdse QkekZL;wfVdYl fy-@eSllZ ,fjl ykbZQ lkbaflt fy-

7.80

4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

MINISTRY OF CHEMICALS AND FERTILIZERS

(Department of Pharmaceuticals)

(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)

ORDER

New Delhi, the 1st January, 2018

S.O. 02(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices

Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March,

2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National

Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in

column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation

to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit

and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4)

and (5) thereof;

TABLE

Sl.

No.

Name of the

Scheduled

Formulation/Brand

Name

Strength Unit Manufacturer &

Marketing Company

Retail

Price (Rs.)

1. Cilnidipine +

Metoprolol Tablet

Each film coated Bi- Layered tablet

contains:

Cilnidipine 10mg,

Metoprolol Succinate IP 47.5mg eq.

to Metoprolol Tartrate 50mg (ER)

1 Tablet M/s. Pure and Cure

Healthcare Pvt Ltd. /

M/s Intas

Pharmaceuticals Pvt.

Ltd.

7.346

2. Metformin +

Glimepiride +

Voglibose Tablets

Each tablet contains:

Metformin HCL 500mg

(as sustained release form)

Glimepiride 1mg

Voglibose 0.3mg

1 Tablet M/s. Sunglow

Pharmaceuticals Pvt.

Ltd. / M/s Intas

Pharmaceuticals Ltd.

8.17

3. Rosuvastatin +

Clopidogrel Capsule

Each Hard gelatin capsule contains:

Rosuvastatin Calcium IP eq. to

Rosuvastatin 20mg,

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg

1 Capsule M/s. Synokem

Pharmaceuticals Ltd. /

M/s Cadila

Pharmaceuticals Ltd.

7.80

4. Telmisartan +

Chlorthalidone Tablet

(Tigatel CH 80)

Each film coated tablet contains:

Telmisartan IP 80mg,

Chlorthalidone IP 12.5mg

1 Tablet M/s. Sun Pharma

Laboratories Limited

6.713

5. Rosuvastatin +

Clopidogrel Capsule

Each hard gelatin capsule contains:

Rosuvastatin Calcium IP eq. to

Rosuvastatin 20mg (As pellets)

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg (As pellets)

1 Capsule M/s. Synokem

Pharmaceuticals Ltd. /

M/s Zydus Healthcare

Ltd.

7.80

6. Paracetamol+Caffeine+

Phenylephrine+

Diphenhydramine

Tablet (Sinus77)

Each uncoated tablet contains:

Paracetamol-500mg

Caffeine (anhydrous)-30mg

Phenylephrine HCl-5mg

Diphenhydramine HCl-25mg

1 Tablet M/s. Dales

Laboratories Pvt. Ltd.

2.57

7. Atorvastatin +

Clopidogrel Capsule

Each hard gelatin capsule contains:

Atorvastatin Calcium IP eq. to

Atorvastatin 10mg,

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg

1 Capsule M/s. Synokem

Pharmaceuticals Ltd. /

M/s Eris Lifesciences

Limited

8.394

8. Atorvastatin +

Clopidogrel Capsule

Each hard gelatin capsule contains:

Atorvastatin Calcium IP eq. to

Atorvastatin 20mg,

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg

1 Capsule M/s. Synokem

Pharmaceuticals Ltd. /

M/s Eris Lifesciences

Limited

10.596

¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5

9. Gliclazide +

Metformin Tablet

(Glychek M +)

Each uncoted tablet contains:

Gliclazide IP 40mg,

Metformin Hydrochloride IP

500mg

1 Tablet M/s. Akums Drugs &

Pharmaceuticals Ltd. /

M/s Indoco Remedies

Limited

4.354

10. Atorvastatin +

Clopidogrel Capsule

(Atocor CV 20mg)

Each hard gelatin capsule contains:

Atorvastatin Calcium IP eq. to

Atorvastatin 20mg (As two film

coated tablet Each containing

Atorvastatin 10mg)

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg (As 2 film

coated 37.5mg each tablet)

1 Capsule M/s. Windlas Biotech

Pvt. Ltd. / M/s Dr.

Reddy’s Laboratories

Ltd.

10.596

11. Atorvastatin +

Clopidogrel Capsule

(Avas 20 Gold)

Each capsule contains:

Atorvastatin Calcium IP eq. to

Atorvastatin 20mg (As film coated

tablet)

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg (As 2 film

coated 37.5mg each tablet)

1 Capsule M/s Micro Lab. Ltd. 10.596

12. Atorvastatin +

Clopidogrel Capsule

(Astin 20 Gold)

Each capsule contains:

Atorvastatin Calcium IP eq. to

Atorvastatin 20mg (As film coated

tablet)

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg (As 2 film

coated 37.5mg each tablet)

1 Capsule M/s Micro Lab. Ltd. 10.596

13. Rosuvastatin +

Clopidogrel Capsule

Each hard gelatin capsule contains:

Rosuvastatin Calcium IP eq. to

Rosuvastatin 10mg,

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg

1 Capsule M/s Synokem

Pharmaceuticals Ltd. /

M/s Eris Lifesciences

Limited

13.37

14. Rosuvastatin +

Clopidogrel Capsule

Each hard gelatin capsule contains:

Rosuvastatin Calcium IP eq. to

Rosuvastatin 20mg,

Clopidogrel Bisulphate IP eq. to

Clopidogrel 75mg

1 Capsule M/s Synokem

Pharmaceuticals Ltd. /

M/s Eris Lifesciences

Limited

7.80

Note:

(a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the

DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to

the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned

manufacturer in accordance with the retail price specified in column (6) of the above table as per

provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list

in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through

IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the

supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the

premises where he carries on business in a manner so as to be easily accessible to any person

wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer/marketeer as

mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/

revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory

requirements as laid down by the Govt. under relevant statutes/rules, including manufacturing

license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may

be applicable, by the concerned manufacturer/marketing companies.

6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

(f) The concerned manufacturer of above said formulations shall furnish quarterly return to the NPPA,

in respect of production / import and sale of product in Form-III of Schedule-II of the DPCO, 2013

through IPDMS. Manufacturer, in case intending to discontinue above said formulations, shall

furnish information to the NPPA, in respect of discontinuation of the production and/or import of

above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to

the intended date of discontinuation.

(g) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price

notification and notes specified hereinabove, then the concerned manufacturer/marketing company

shall be liable to deposit the overcharged amount along with the interest thereon under the

provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(h) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above

table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the

above said date of notification, stand(s) superseded.

[PN/184/52/2017/F/F. No. 8(52)/2017/D.P./NPPA-Div.-II]

BALJIT SINGH, Assistant Director

Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064

and Published by the Controller of Publications, Delhi-110054.